Boothbay Fund Management’s Anebulo Pharmaceuticals ANEB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1K | Hold |
18,836
| – | – | ﹤0.01% | 1187 |
|
|
2025
Q1 | $24.5K | Hold |
18,836
| – | – | ﹤0.01% | 1151 |
|
|
2024
Q4 | $31.6K | Sell |
18,836
-142
| -0.7% | -$239 | ﹤0.01% | 1239 |
|
|
2024
Q3 | $36.6K | Hold |
18,978
| – | – | ﹤0.01% | 1332 |
|
|
2024
Q2 | $51.8K | Hold |
18,978
| – | – | ﹤0.01% | 1245 |
|
|
2024
Q1 | $54.5K | Hold |
18,978
| – | – | ﹤0.01% | 1290 |
|
|
2023
Q4 | $45.9K | Hold |
18,978
| – | – | ﹤0.01% | 1366 |
|
|
2023
Q3 | $58K | Buy |
18,978
+1,659
| +10% | +$5.07K | ﹤0.01% | 1420 |
|
|
2023
Q2 | $40.7K | Hold |
17,319
| – | – | ﹤0.01% | 1461 |
|
|
2023
Q1 | $50.2K | Hold |
17,319
| – | – | ﹤0.01% | 1769 |
|
|
2022
Q4 | $42K | Hold |
17,319
| – | – | ﹤0.01% | 1642 |
|
|
2022
Q3 | $48K | Sell |
17,319
-14
| -0.1% | -$39 | ﹤0.01% | 1832 |
|
|
2022
Q2 | $90K | Hold |
17,333
| – | – | ﹤0.01% | 1736 |
|
|
2022
Q1 | $123K | Hold |
17,333
| – | – | ﹤0.01% | 1668 |
|
|
2021
Q4 | $110K | Hold |
17,333
| – | – | ﹤0.01% | 1527 |
|
|
2021
Q3 | $114K | Sell |
17,333
-2,502
| -13% | -$16.5K | ﹤0.01% | 1533 |
|
|
2021
Q2 | $135K | Buy |
+19,835
| New | +$135K | ﹤0.01% | 1504 |
|